Researchers at the University of Canberra will collaborate with a pharmaceutical company to test the efficacy of medicinal cannabis in treating melanoma.

The university announced a $1 million deal with Israel-based Cann Pharmaceutical to provide specific medical-grade strains of cannabis, which will be administered to patients along with the current standard of care for melanoma patients.

Molecular and cellular biology professor Sudha Rao said the research could benefit the almost-55,000 Australians that live with the skin cancer.

Click here to read the complete article

abc.net.au/news ~

Recent News Articles

Monday June 17

Hemp, and hope, sprouts in Minnesota fields - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

It’s springtime for hemp — the dawn of a new age for Minnesota agriculture.

824 hits

Monday June 17

Scottish mum praises effects of banned cannabis oil on son’s epilepsy - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

Karen can only get the cannabis oil by travelling abroad – and to bring it…

494 hits

Monday June 17

As Medical Cannabis Moves Mainstream, are Rheumatologists Prepared? - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

As more and more patients are using the drug, either legally or illegally depending on…

534 hits

Monday June 17

How to Eat, Drink, and Appreciate Cannabis at Restaurants - Cannabis News

in Culture & Arts

by Bruce Kennedy - Editor in Chief

From infusions to strain-specific cooking, veteran chefs are forging new identities while up-and-comers are making…

520 hits

Tuesday June 18

United States of Weed - Cannabis News

in Law & Crime

by Bruce Kennedy - Editor in Chief

Curious about the status of cannabis? Here’s a map of where marijuana legalization stands across…

212 hits